Skip to content

Electroacupoint for Diminutive Milk Production

Ameliorative Potential of Electroacupoint for Diminutive Milk Production in Lactating Woman

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06590805
Enrollment
36
Registered
2024-09-19
Start date
2024-09-01
Completion date
2025-06-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Modification, Electrotherapy, Physical Therapy

Keywords

Electroacupoint, Postnatal care, Diminutive milk production, Lactating woman

Brief summary

The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.

Detailed description

Postnatal scanty milk secretion is a common complaint. Some physical and medicinal therapies have been proposed to enhance milk production. These therapies must be both successful and safe for both the mother and the child. In many cases, milk supply can be increased by frequent, regular milk removal, Medication to increase milk supply (galactogogues) such as domperidone. Domperidone has been linked to maternal adverse effects in galactogogue trials and cases reported to the Food and Drug Administration include dry mouth, headache, dizziness, nausea, abdominal cramping, diarrhea, palpitations malaise, and shortness of breath. Some of these were more frequent with dosages greater than with 30 mg daily. Drug withdrawal symptoms consisting of insomnia, anxiety, and tachycardia were reported in a woman taking 80 mg of domperidone daily for 8 months as a galactogogue who abruptly tapered the dose over 3 days.

Interventions

PROCEDUREElectrotherapy using Chattanooga stimulation unit

Electroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.

DIETARY_SUPPLEMENTBalanced Diet using domperidone drug, iron, and folic acid supplementation.

Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care. It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.

Sponsors

Haytham Ibrahim Morsi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Two Parallel Groups for Comparison.

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* They were complaining of insufficiency of lactation within the first month after cesarean section. * They are using mixed feeding; both breast and bottle feeding, between three and six bottles per day. * Their age ranged from 25-30 years old. * Their body mass index didn't exceeded 30 kg/m2.

Exclusion criteria

* Postpartum haemorrhage. * Cardiorespiratory disease. * Diabetes mellitus. * Breast cancer. * Previous surgeries in the chest, breast, or the surrounding area. * Anemia. * Any causes that hindered their normal breastfeeding (retraced, cracked, inflamed, or inverted nipples). * Receiving contraceptive pills. * Having infants with conditions that may affect the lactation process such as congenital abnormalities of the mouth (tongue tie, cleft palate). * Congenital heart disease.

Design outcomes

Primary

MeasureTime frameDescription
Change in Baby Weight.Change from Baseline Baby Weight at three months.Measurement of Baby Weight using the Baby Weight Scale.
Change in Serum Prolactin Level.Change from Baseline Serum Prolactin Level at three months.Measurement of Serum Prolactin Level using the Serum Blood Test.
Change in Flow of Milk.Change from Baseline Flow of Milk at three months.Measurement of Flow of Milk using the Visual Analogue Scale.

Countries

Egypt

Contacts

Primary ContactSara E Seyam, B.Sc.
saraseyam2024@gmail.com+201554552868
Backup ContactHaytham I Morsi, M.Sc.
haytham_morsi@kfs.edu.eg+201013657738

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026